Ligand validation:5JM1

AMG: methyl alpha-D-galactopyranoside

AMG is a Ligand Of Interest in 5JM1 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5JM1_AMG_G_205	78%	4%	0.104	0.946	2.82	2.93	5	8	0	0	100%	1
1JAC_AMG_A_200	93%	12%	0.074	0.968	1.59	2.49	2	7	0	0	100%	1
1TOQ_AMG_A_501	89%	57%	0.103	0.982	0.55	1.07	-	2	0	0	100%	1
1TP8_AMG_A_500	87%	49%	0.103	0.977	0.56	1.4	-	1	0	0	100%	1
1WS4_AMG_E_503	66%	31%	0.113	0.917	1.54	1.23	3	2	0	1	100%	0.9369
4NDU_AMG_A_101	99%	57%	0.047	0.981	0.84	0.81	1	-	0	0	100%	1
4DDN_AMG_A_200	96%	28%	0.067	0.974	1.89	1.03	4	1	0	0	100%	1
2Z49_AMG_A_1400	95%	64%	0.07	0.974	0.73	0.64	1	-	0	0	100%	1
1WBL_AMG_B_400	94%	28%	0.073	0.972	1.33	1.56	1	4	0	0	100%	1
3CA5_AMG_A_267	93%	52%	0.075	0.969	0.75	1.09	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.